News
-
-
-
-
PRESS RELEASE
Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts
Jaguar Health, Inc. to present virtually at Life Sciences Investor Forum on March 12, 2026. More about Jaguar's novel prescription drugs for gastrointestinal diseases -
-
PRESS RELEASE
NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete
NanoViricides, Inc. announces completion of manufacture for NV-387 Oral Gummies clinical trial. President to present at NIBA conference. Lead drug NV-387 to target various viral infections -
-
PRESS RELEASE
GameSquare Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
GameSquare Holdings, Inc. receives Nasdaq approval for bid price extension until September 7, 2026. Company planning necessary actions to regain compliance with Nasdaq listing requirements -
-
PRESS RELEASE
Wolftank Group successfully completes hydrogen infrastructure order for TPER – second refueling station in Bologna finalized
Wolftank Group completes hydrogen infrastructure project for TPER, enabling zero-emission mobility in public transport with state-of-the-art technology. Project delivered on schedule
